Value in Health

Podium Presentations
pp. A1-A28(28)

Poster Presentations
pp. A29-A311(283)

DISCLOSURE INFORMATION
pp. A312-A321(10)

Abstracts Index
pp. A322-A333(12)

Cost-Effectiveness of Intraperitoneal Chemohyperthermia in the Treatment of Peritoneal Carcinomatosis from Colorectal Cancer
pp. 347-353(7)
Authors: Bonastre, Julia; Chevalier, Julie; Elias, Dominique; Classe, Jean Marc; Ferron, Gwenaël; Guilloit, Jean Marc; Marchal, Frédéric; Meeus, Pierre; De Pouvourville, Gerard

An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy
pp. 354-364(11)
Authors: Annemans, Lieven; Demarteau, Nadia; Hu, Shanlian; Lee, Tae-Jin; Morad, Zaher; Supaporn, Thanom; Yang, Wu-Chang; Palmer, Andrew J.

Assessing the Impact of Censoring of Costs and Effects on Health-Care Decision-Making: an Example Using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study
pp. 365-375(11)
Authors: Fenwick, Elisabeth; Marshall, Deborah A.; Blackhouse, Gordon; Vidaillet, Humberto; Slee, April; Shemanski, Lynn; Levy, Adrian R.

A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom
pp. 376-388(13)
Authors: Cottrell, Suzi; Tilden, Dominic; Robinson, Paul; Bae, Jay; Arellano, Jorge; Edgell, Eric; Aristides, Mike; Boye, Kristina S.

Cost-Utility Analysis of Rimonabant in the Treatment of Obesity
pp. 389-399(11)
Authors: Hampp, Christian; Hartzema, Abraham G.; Kauf, Teresa L.

Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment
pp. 400-407(8)
Authors: Gelfand, Joel M.; Kimball, Alexa B.; Mostow, Eliot N.; Chiou, Chiun-Fang; Patel, Vaishali; Xia, H. Amy; Freundlich, Bruce; Stevens, Seth R.

The Burden of Ankylosing Spondylitis in Spain
pp. 408-415(8)
Authors: Kobelt, Gisela; Sobocki, Patrik; Mulero, Juan; Gratacos, Jordi; Pocovi, Ana; Collantes-Estevez, Eduardo

Treatment Costs and Health Care Utilization for Patients with Bipolar Disorder in a Large Managed Care Population
pp. 416-423(8)
Authors: Guo, Jeff J.; Keck, Paul E.; Li, Hong; Jang, Raymond; Kelton, Christina M. L.

Uncertainty in Decision-Making: Value of Additional Information in the Cost-Effectiveness of Lifestyle Intervention in Overweight and Obese People
pp. 424-434(11)
Authors: Galani, Carmen; Al, Maiwenn; Schneider, Heinz; Rutten, Frans F. H.

Reliability of Two Instruments for Critical Assessment of Economic Evaluations
pp. 435-439(5)
Authors: Au, Flora; Prahardhi, Shirlina; Shiell, Alan

Validity of the Health Profile-Types of the Spanish Child Health and Illness Profile-Adolescent Edition (CHIP-AE)
pp. 440-449(10)
Authors: Alonso, Jordi; Urzola, Diana; Serra-Sutton, Vicky; Tebé, Cristian; Starfield, Barbara; Riley, Anne W.; Rajmil, Luis

Diabetes-Specific or Generic Measures for Health-Related Quality of Life? Evidence from Psychometric Validation of the D-39 and SF-36
pp. 450-461(12)
Authors: Huang, I-Chan; Hwang, Chyng-Chuang; Wu, Ming-Yen; Lin, Wender; Leite, Walter; Wu, Albert W.

A Longitudinal Analysis of Outcomes Associated with Abciximab and Eptifibatide in a Consecutive Series of 3074 Percutaneous Coronary Interventions
pp. 462-469(8)
Authors: Long, Kirsten H.; Ting, Henry H.; McMurtry, Erin K.; Lennon, Ryan J.; Wood, Douglas L.; Holmes, David R.; Raveendran, Ganesh; Rihal, Charanjit S.

Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip
pp. 470-477(8)
Authors: Marshall, Deborah; Pericak, Dan; Grootendorst, Paul; Gooch, Katherine; Faris, Peter; Frank, Cy; Bellamy, Nicholas; Torrance, George; Feeny, David

The Impact of Body Weight on Patient Utilities with or without Type 2 Diabetes: A Review of the Medical Literature
pp. 478-486(9)
Authors: Dennett, Susan L.; Boye, Kristina S.; Yurgin, Nicole R.

Duration of Antipsychotic Drug Therapy in Real-World Practice: A Comparison with CATIE Trial Results
pp. 487-496(10)
Authors: Chen, Lei; McCombs, Jeffrey S.; Park, Jinhee

Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures
pp. 497-508(12)
Authors: Payne, Katherine; Nicholls, Stuart; McAllister, Marion; MacLeod, Rhona; Donnai, Dian; Davies, Linda M.

Literature Review of Methods to Translate Health-Related Quality of Life Questionnaires for Use in Multinational Clinical Trials
pp. 509-521(13)
Authors: Acquadro, Catherine; Conway, Katrin; Hareendran, Asha; Aaronson, Neil

Time and Expected Value of Sample Information Wait for No Patient
pp. 522-526(5)
Authors: Eckermann, Simon; Willan, Andrew R.

The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons
pp. 527-538(12)
Authors: Levy, Adrian R.; Kowdley, Kris V.; Iloeje, Uchenna; Tafesse, Eskinder; Mukherjee, Jayanti; Gish, Robert; Bzowej, Natalie; Briggs, Andrew H.